Caldera Therapeutics
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
300 Technology Sq Ste 8, Cambridge, Mass...Website
www.calderatx.comRevenue
<$5 MillionIndustry
About Caldera Therapeutics
Caldera Therapeutics Org Chart
Is Caldera Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Caldera Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Caldera Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Caldera Therapeutics had a recent Job posting/layoffs
Check out if Caldera Therapeutics is spiking on competitors!
Earning: See what the market has to say on Caldera Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Caldera Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Caldera Therapeutics
Product Launch: Get notified when Caldera Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Caldera Therapeutics as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Caldera Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Caldera Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Caldera Therapeutics.
Caldera Therapeutics financials insights
Gather financial insights about Caldera Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$37.5M
Series A
$75M
Top Business Services Companies
Frequently Asked Questions Regarding Caldera Therapeutics
Caldera Therapeutics is a clinical stage company developing CLD-423, a first-in-class bispecific antibody targeting the clinically validated IL-23p19 and TL1A pathways for the treatment of inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases. Supported by leading biotech investors Atlas Venture, LAV, venBio, Omega Funds,... Read More


